Table 1.
The association of SNHG26 expression in forty-two TSCC patients with clinicopathologic characteristics
| Characteristic | Low expression of SNHG26 | High expression of SNHG26 | p value |
|---|---|---|---|
| n | 21 | 21 | |
| Age, n (%) | 0.758 | ||
| ≤50 | 10 (47.6%) | 11 (52.4%) | |
| >50 | 11 (52.4%) | 10 (47.6%) | |
| Gender, n (%) | 0.217 | ||
| Female | 9 (42.9%) | 13 (61.9%) | |
| Male | 12 (57.1%) | 8 (38.1%) | |
| T stage, n (%) | 0.030∗ | ||
| T1/T2 | 15 (71.4%) | 8 (28.6%) | |
| T3/T4 | 6 (38.1%) | 13 (61.9%) | |
| N stage, n (%) | 0.537 | ||
| N0 | 11 (52.4%) | 9 (42.9%) | |
| N+ | 10 (47.6%) | 12 (57.1%) | |
| Clinical stage, n (%) | 0.533 | ||
| I/II | 10 (47.6%) | 8 (38.1%) | |
| III/IV | 11 (52.4%) | 13 (61.9%) | |
| Histologic grade, n (%) | 0.013∗ | ||
| G1 | 14 (66.7%) | 6 (28.6%) | |
| G2/G3 | 7 (33.3%) | 15 (71.4%) | |
| Lymphovascular invasion, n (%) | 0.346 | ||
| No | 10 (47.6%) | 7 (33.3%) | |
| Yes | 11 (52.4%) | 14 (66.7%) | |
∗p < 0.05 TNM staging was performed using the 8th edition of the AJCC staging system for oral cancer.